- Medicine Name: Korsuva
Generic Name: Difelikefalin
Dosage Form & Strength: Injection: 65 mcg /1.3 mL (50 mcg/mL) of difelikefalin
Manufactured By: Cara Therapeutics, Inc.
Korsuva is a kappa opioid receptor agonist used for the treatment of moderate-to-severe pruritus (itching) associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis (HD). This medicinal product is not for use in individuals undergoing peritoneal dialysis (fluid taken from the abdomen).
Recommended Dosage: The recommended dosage of Korsuva is 0.5 mcg per kg given by intravenous bolus injection into the venous line of the dialysis circuit post each hemodialysis treatment. In case a regularly scheduled hemodialysis treatment is skipped/missed, resume treatment at the end of the next hemodialysis treatment.
Avoid mixing or diluting korsuva injection 65 mcg/1.3 mL (50 mcg/mL) prior to administration. Use the drug within 60 minutes of syringe preparation.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.